by In2Pharma | Jul 3, 2025 | News
Europe As of October 17, 2023, the EU’s new microplastics restriction under the REACH regulation has officially entered into force (Commission Regulation (EU) 2023/2055). This restriction bans the sale of products containing intentionally added microplastics,...
by In2Pharma | Dec 18, 2018 | News
EMA Following a review of disabling and potential long-term side effects of fluoroquinolone and quinolone antibiotics, the Pharmacovigilance Risk Assessment Committee (PRAC) has recommended a restriction of the use of these products. It concerns fluoroquinolone and...
